| 000 | 01484 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250511131006.0 | ||
| 264 | 0 | _c19790526 | |
| 008 | 197905s 0 0 eng d | ||
| 022 | _a0028-4793 | ||
| 024 | 7 |
_a10.1056/NEJM197904193001604 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYu, V L | |
| 245 | 0 | 0 |
_aSerratia marcescens: historical perspective and clinical review. _h[electronic resource] |
| 260 |
_bThe New England journal of medicine _cApr 1979 |
||
| 300 |
_a887-93 p. _bdigital |
||
| 500 | _aPublication Type: Historical Article; Journal Article; Review | ||
| 650 | 0 | 4 | _aAerosols |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBiological Warfare |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aCross Infection _xepidemiology |
| 650 | 0 | 4 | _aDrug Contamination |
| 650 | 0 | 4 |
_aEndocarditis, Bacterial _xetiology |
| 650 | 0 | 4 |
_aEnterobacteriaceae Infections _xdrug therapy |
| 650 | 0 | 4 | _aHistory, Ancient |
| 650 | 0 | 4 | _aHistory, Medieval |
| 650 | 0 | 4 | _aHistory, Modern 1601- |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInjections, Intravenous _xadverse effects |
| 650 | 0 | 4 |
_aMicrobiology _xhistory |
| 650 | 0 | 4 |
_aSepsis _xetiology |
| 650 | 0 | 4 |
_aSerratia marcescens _xisolation & purification |
| 650 | 0 | 4 |
_aSubstance-Related Disorders _xcomplications |
| 650 | 0 | 4 | _aUnited States |
| 773 | 0 |
_tThe New England journal of medicine _gvol. 300 _gno. 16 _gp. 887-93 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJM197904193001604 _zAvailable from publisher's website |
| 999 |
_c392274 _d392274 |
||